Rational design of gene‐based vaccines
- 17 December 2005
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 208 (2) , 283-289
- https://doi.org/10.1002/path.1874
Abstract
Vaccine development has traditionally been an empirical discipline. Classical vaccine strategies include the development of attenuated organisms, whole killed organisms, and protein subunits, followed by empirical optimization and iterative improvements. While these strategies have been remarkably successful for a wide variety of viruses and bacteria, these approaches have proven more limited for pathogens that require cellular immune responses for their control. In this review, current strategies to develop and optimize gene‐based vaccines are described, with an emphasis on novel approaches to improve plasmid DNA vaccines and recombinant adenovirus vector‐based vaccines. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 91 references indexed in Scilit:
- β–Amino Ester Polymers Facilitate in Vivo DNA Transfection and Adjuvant Plasmid DNA ImmunizationMolecular Therapy, 2005
- Priming with Plasmid DNAs Expressing Interleukin-12 and Simian Immunodeficiency Virus Gag Enhances the Immunogenicity and Efficacy of an Experimental AIDS Vaccine Based on Recombinant Vesicular Stomatitis VirusAIDS Research and Human Retroviruses, 2005
- Neutralizing Antibodies and CD8 + T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine VectorsJournal of Virology, 2004
- Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United StatesClinical and Vaccine Immunology, 2004
- Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 VaccinesJournal of Virology, 2003
- Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus ImmunityJournal of Virology, 2003
- The Adenovirus Capsid Protein Hexon Contains a Highly Conserved Human CD4+T-Cell EpitopeHuman Gene Therapy, 2002
- Hexon Gene Switch Strategy for the Generation of Chimeric Recombinant AdenovirusHuman Gene Therapy, 2002
- DNA VACCINESAnnual Review of Immunology, 1997
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993